Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 364260, 10 pages
http://dx.doi.org/10.1155/2015/364260
Review Article

A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal Dysfunction

1Tsumura Research Laboratories, Tsumura & Co., 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki 300-1192, Japan
2Pathophysiology and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060-0812, Japan
3Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido 060-8638, Japan

Received 4 July 2014; Revised 26 September 2014; Accepted 7 October 2014

Academic Editor: Jieyun Yin

Copyright © 2015 Yayoi Saegusa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Stanghellini, C. Tosetti, A. Paternico et al., “Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia,” Gastroenterology, vol. 110, no. 4, pp. 1036–1042, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Tack, H. Piessevaux, B. Coulie, P. Caenepeel, and J. Janssens, “Role of impaired gastric accommodation to a meal in functional dyspepsia,” Gastroenterology, vol. 115, no. 6, pp. 1346–1352, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Aro, N. J. Talley, J. Ronkainen et al., “Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study,” Gastroenterology, vol. 137, no. 1, pp. 94–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Aro, N. J. Talley, L. Agréus et al., “Functional dyspepsia impairs quality of life in the adult population,” Alimentary Pharmacology and Therapeutics, vol. 33, no. 11, pp. 1215–1224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. N. J. Talley, G. R. Locke III, B. D. Lahr et al., “Functional dyspepsia, delayed gastric emptying, and impaired quality of life,” Gut, vol. 55, no. 7, pp. 933–939, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Meineche-Schmidt, N. J. Talley, A. Pap et al., “Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study,” Scandinavian Journal of Gastroenterology, vol. 34, no. 6, pp. 566–574, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Suzuki, J. M. Inadomi, and T. Hibi, “Japanese herbal medicine in functional gastrointestinal disorders,” Neurogastroenterology & Motility, vol. 21, no. 7, pp. 688–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Tominaga and T. Arakawa, “Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application,” Journal of Gastroenterology, vol. 48, no. 4, pp. 452–462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Oka, H. Okumi, S. Nishida et al., “Effects of Kampo on functional gastrointestinal disorders,” BioPsychoSocial Medicine, vol. 8, no. 1, article 5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Tatsuta and H. Iishi, “Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients,” Alimentary Pharmacology & Therapeutics, vol. 7, no. 4, pp. 459–462, 1993. View at Google Scholar · View at Scopus
  11. T. Hattori, “Rikkunshito and ghrelin,” International Journal of Peptides, vol. 2010, Article ID 283549, 3 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Hattori, N. Fujitsuka, A. Asakawa, and A. Inui, “A new strategy using Rikkunshito (Liu-Jun-Zi-Tang), a Japanese traditional medicine, to treat gastrointestinal disease,” in Basics of Evidences-Based Herbal Medicine, H. Satoh, Ed., pp. 149–160, Research Signpost, Kerala, India, 2010. View at Google Scholar
  13. H. Suzuki, J. Matsuzaki, Y. Fukushima et al., “Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia—a multicenter, double-blind, randomized, placebo-controlled study,” Neurogastroenterology & Motility, vol. 26, no. 7, pp. 950–961, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, “Ghrelin is a growth-hormone-releasing acylated peptide from stomach,” Nature, vol. 402, no. 6762, pp. 656–660, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. C. De Vriese, F. Gregoire, R. Lema-Kisoka, M. Waelbroeck, P. Robberecht, and C. Delporte, “Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites,” Endocrinology, vol. 145, no. 11, pp. 4997–5005, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Nakazato, N. Murakami, Y. Date et al., “A role for ghrelin in the central regulation of feeding,” Nature, vol. 409, no. 6817, pp. 194–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Date, N. Murakami, K. Toshinai et al., “The role of the gastric afferent vagal nerve in Ghrelin-induced feeding and growth hormone secretion in rats,” Gastroenterology, vol. 123, no. 4, pp. 1120–1128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Fujitsuka, A. Asakawa, M. Hayashi et al., “Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin,” Biological Psychiatry, vol. 65, no. 9, pp. 748–759, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ariga, K. Tsukamoto, C. Chen, C. Mantyh, T. N. Pappas, and T. Takahashi, “Endogenous acyl ghrelin is involved in mediating spontaneous phase III-like contractions of the rat stomach,” Neurogastroenterology and Motility, vol. 19, no. 8, pp. 675–680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. de Vry and R. Schreiber, “Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action,” Neuroscience and Biobehavioral Reviews, vol. 24, no. 3, pp. 341–353, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. D. E. Wright, K. B. Seroogy, K. H. Lundgren, B. M. Davis, and L. Jennes, “Comparative localization of serotonin1A, 1C and 2 receptor subtype mRNAs in rat brain,” Journal of Comparative Neurology, vol. 351, no. 3, pp. 357–373, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Dryden, Q. Wang, H. M. Frankish, and G. Williams, “Differential effects of the 5-HT1B/2C receptor agonist mCPP and the 5-HT1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: evidence that NPY may mediate serotonin's effects on food intake,” Peptides, vol. 17, no. 6, pp. 943–949, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. M. B. Gatch, “Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety,” Life Sciences, vol. 73, no. 11, pp. 1347–1367, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Hayashi, M. Suzuki, M. Sasamata, and K. Miyata, “Agonist diversity in 5-HT2C receptor-mediated weight control in rats,” Psychopharmacology, vol. 178, no. 2-3, pp. 241–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Halford, J. A. Harrold, E. J. Boyland, C. L. Lawton, and J. E. Blundell, “Serotonergic drugs: effects on appetite expression and use for the treatment of obesity,” Drugs, vol. 67, no. 1, pp. 27–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Nonogaki, “Ghrelin and feedback systems,” Vitamins and Hormones, vol. 77, pp. 149–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. L. K. Heisler, M. A. Cowley, L. H. Tecott et al., “Activation of central melanocortin pathways by fenfluramine,” Science, vol. 297, no. 5581, pp. 609–611, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Takeda, C. Sadakane, T. Hattori et al., “Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism,” Gastroenterology, vol. 134, no. 7, pp. 2004–2013, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Saegusa, H. Takeda, S. Muto et al., “Decreased plasma ghrelin contributes to anorexia following novelty stress,” American Journal of Physiology—Endocrinology and Metabolism, vol. 301, no. 4, pp. E685–E696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Nahata, S. Muto, K. Nakagawa et al., “Serotonin 2C receptor antagonism ameliorates novelty-induced hypophagia in aged mice,” Psychoneuroendocrinology, vol. 38, no. 10, pp. 2051–2064, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. D. Kursar, D. L. Nelson, D. B. Wainscott, M. L. Cohen, and M. Baez, “Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus,” Molecular Pharmacology, vol. 42, no. 4, pp. 549–557, 1992. View at Google Scholar · View at Scopus
  32. D.-S. Choi and L. Maroteaux, “Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain,” FEBS Letters, vol. 391, no. 1-2, pp. 45–51, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Hattori, K. Yakabi, and H. Takeda, “Cisplatin-induced anorexia and ghrelin,” Vitamins and Hormones, vol. 92, pp. 301–317, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Ohno, S. Kato, M. Wakatsuki et al., “Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone,” Gynecologic Oncology, vol. 103, no. 1, pp. 94–99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Ozaki and T. Sukamoto, “Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist,” General Pharmacology, vol. 33, no. 3, pp. 283–288, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. L. X. Cubeddu and I. S. Hoffmann, “Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics,” Journal of Clinical Pharmacology, vol. 33, no. 8, pp. 691–697, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. B. C. de Jonghe and C. C. Horn, “Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 294, no. 3, pp. R756–R765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Yakabi, C. Sadakane, M. Noguchi et al., “Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia,” Endocrinology, vol. 151, no. 8, pp. 3773–3782, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Ohno, M. Yanai, H. Ando et al., “Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans,” Clinical and Experimental Gastroenterology, vol. 4, no. 1, pp. 291–296, 2011. View at Google Scholar · View at Scopus
  40. Y. Hiura, S. Takiguchi, K. Yamamoto et al., “Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients,” International Journal of Clinical Oncology, vol. 17, no. 4, pp. 316–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Yakabi, S. Kurosawa, M. Tamai et al., “Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction,” Regulatory Peptides, vol. 161, no. 1–3, pp. 97–105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Kido, Y. Nakai, Y. Kase et al., “Effects of Rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by NG-nitro-L-arginine,” Journal of Pharmacological Sciences, vol. 98, no. 2, pp. 161–167, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. K. A. Youdim, M. S. Dobbie, G. Kuhnle, A. R. Proteggente, N. J. Abbott, and C. Rice-Evans, “Interaction between flavonoids and the blood-brain barrier: in vitro studies,” Journal of Neurochemistry, vol. 85, no. 1, pp. 180–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Sadakane, S. Muto, K. Nakagawa et al., “10-Gingerol, a component of rikkunshito, improves cisplatin-induced anorexia by inhibiting acylated ghrelin degradation,” Biochemical and Biophysical Research Communications, vol. 412, no. 3, pp. 506–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Steptoe, N. Owen, S. R. Kunz-Ebrecht, and L. Brydon, “Loneliness and neuroendocrine, cardiovascular, and inflammatory stress responses in middle-aged men and women,” Psychoneuroendocrinology, vol. 29, no. 5, pp. 593–611, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Ó. Luanaigh and B. A. Lawlor, “Loneliness and the health of older people,” International Journal of Geriatric Psychiatry, vol. 23, no. 12, pp. 1213–1221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Bhatia and R. K. Tandon, “Stress and the gastrointestinal tract,” Journal of Gastroenterology and Hepatology, vol. 20, no. 3, pp. 332–339, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. C. lo Sauro, C. Ravaldi, P. L. Cabras, C. Faravelli, and V. Ricca, “Stress, hypothalamic-pituitary-adrenal axis and eating disorders,” Neuropsychobiology, vol. 57, no. 3, pp. 95–115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. O. Martí, J. Martí, and A. Armario, “Effects of chronic stress on food intake in rats: influence of stressor intensity and duration of daily exposure,” Physiology and Behavior, vol. 55, no. 4, pp. 747–753, 1994. View at Publisher · View at Google Scholar · View at Scopus
  50. I. I. Rybkin, Y. Zhou, J. Volaufova, G. N. Smagin, D. H. Ryan, and R. B. S. Harris, “Effect of restraint stress on food intake and body weight is determined by time of day,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 273, no. 5, part 2, pp. R1612–R1622, 1997. View at Google Scholar · View at Scopus
  51. A. Vallès, O. Martí, A. García, and A. Armario, “Single exposure to stressors causes long-lasting, stress-dependent reduction of food intake in rats,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 279, no. 3, pp. R1138–R1144, 2000. View at Google Scholar · View at Scopus
  52. M. Hotta, T. Shibasaki, K. Aral, and H. Demura, “Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats,” Brain Research, vol. 823, no. 1-2, pp. 221–225, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Sakakibara, A. Suzuki, A. Kobayashi et al., “Social isolation stress induces hepatic hypertrophy in C57BL/6J mice,” Journal of Toxicological Sciences, vol. 37, no. 5, pp. 1071–1076, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Kristenssson, M. Sundqvist, M. Astin et al., “Acute psychological stress raises plasma ghrelin in the rat,” Regulatory Peptides, vol. 134, no. 2-3, pp. 114–117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Lutter, I. Sakata, S. Osborne-Lawrence et al., “The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress,” Nature Neuroscience, vol. 11, no. 7, pp. 752–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Zheng, A. Dobner, R. Babygirija, K. Ludwig, and T. Takahashi, “Effects of repeated restraint stress on gastric motility in rats,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 296, no. 5, pp. R1358–R1365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. V. Rouach, M. Bloch, N. Rosenberg et al., “The acute ghrelin response to a psychological stress challenge does not predict the post-stress urge to eat,” Psychoneuroendocrinology, vol. 32, no. 6, pp. 693–702, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Stengel, M. Goebel, A. Luckey, P.-Q. Yuan, L. Wang, and Y. Taché, “Cold ambient temperature reverses abdominal surgery-induced delayed gastric emptying and decreased plasma ghrelin levels in rats,” Peptides, vol. 31, no. 12, pp. 2229–2235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. P. J. Tomasik, K. Sztefko, and M. Pizon, “The effect of short-term cold and hot exposure on total plasma ghrelin concentrations in humans,” Hormone and Metabolic Research, vol. 37, no. 3, pp. 189–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. N. R. Basa, L. Wang, J. R. Arteaga, D. Heber, E. H. Livingston, and Y. Taché, “Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats,” Neuroscience Letters, vol. 343, no. 1, pp. 25–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Hataya, T. Akamizu, H. Hosoda et al., “Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome,” Endocrinology, vol. 144, no. 12, pp. 5365–5371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Stengel, M. Goebel, L. Wang, J. R. Reeve Jr., Y. Taché, and N. W. G. Lambrecht, “Lipopolysaccharide differentially decreases plasma acyl and desacyl ghrelin levels in rats: potential role of the circulating ghrelin-acylating enzyme GOAT,” Peptides, vol. 31, no. 9, pp. 1689–1696, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Tanaka, A. Asakawa, M. Ushikai et al., “Comparison of the anorexigenic activity of CRF family peptides,” Biochemical and Biophysical Research Communications, vol. 390, no. 3, pp. 887–891, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Yakabi, M. Noguchi, S. Ohno et al., “Urocortin 1 reduces food intake and ghrelin secretion via CRF2 receptors,” American Journal of Physiology: Endocrinology and Metabolism, vol. 301, no. 1, pp. E72–E82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. M. E. Davis, C. J. Pemberton, T. G. Yandle et al., “Urocortin-1 infusion in normal humans,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 3, pp. 1402–1409, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Shiiya, H. Ueno, K. Toshinai et al., “Significant lowering of plasma ghrelin but not des-acyl ghrelin in response to acute exercise in men,” Endocrine Journal, vol. 58, no. 5, pp. 335–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Nahata, Y. Saegusa, C. Sadakane et al., “Administration of exogenous acylated ghrelin or rikkunshito, an endogenous ghrelin enhancer, improves the decrease in postprandial gastric motility in an acute restraint stress mouse model,” Neurogastroenterology and Motility, vol. 26, no. 6, pp. 821–831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. L. M. Donini, C. Savina, and C. Cannella, “Eating habits and appetite control in the elderly: the anorexia of aging,” International Psychogeriatrics, vol. 15, no. 1, pp. 73–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Hughes, K. M. Bennett, and M. M. Hetherington, “Old and alone: barriers to healthy eating in older men living on their own,” Appetite, vol. 43, no. 3, pp. 269–276, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. R. J. Handa, M. K. Cross, M. George et al., “Neuroendocrine and neurochemical responses to novelty stress in young and old male F344 rats: effects of d-fenfluramine treatment,” Pharmacology, Biochemistry and Behavior, vol. 46, no. 1, pp. 101–109, 1993. View at Publisher · View at Google Scholar · View at Scopus
  71. K. C. F. Fone, K. Shalders, Z. D. Fox, R. Arthur, and C. A. Marsden, “Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation,” Psychopharmacology, vol. 123, no. 4, pp. 346–352, 1996. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Miura, H. Qiao, and T. Ohta, “Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress,” Synapse, vol. 46, no. 2, pp. 116–124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Yamada, Y. Saegusa, K. Nakagawa et al., “Rikkunshito, a japanese kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2b receptor signaling in a Novelty Stress Murine Model,” BioMed Research International, vol. 2013, Article ID 792940, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. L. K. Heisler, N. Pronchuk, K. Nonogaki et al., “Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation,” The Journal of Neuroscience, vol. 27, no. 26, pp. 6956–6964, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Nonogaki, K. Nozue, Y. Takahashi et al., “Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT 2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors,” International Journal of Neuropsychopharmacology, vol. 10, no. 5, pp. 675–681, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Kageyama, F. Tozawa, N. Horiba, H. Watanobe, and T. Suda, “Serotonin stimulates corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats,” Neuroscience Letters, vol. 243, no. 1–3, pp. 17–20, 1998. View at Publisher · View at Google Scholar · View at Scopus
  77. S. K. Hemrick-Luecke and D. C. Evans, “Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)2 receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT2A receptor mediation of the HPA axis,” Neuropharmacology, vol. 42, no. 2, pp. 162–169, 2002. View at Publisher · View at Google Scholar · View at Scopus
  78. N. Fujitsuka, A. Asakawa, Y. Uezono et al., “Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival,” Translational Psychiatry, vol. 1, article e23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. J. E. Morley, “Anorexia in older persons: epidemiology and optimal treatment,” Drugs and Aging, vol. 8, no. 2, pp. 134–155, 1996. View at Publisher · View at Google Scholar · View at Scopus
  80. J. E. Morley, “Anorexia of aging: physiologic and pathologic,” American Journal of Clinical Nutrition, vol. 66, no. 4, pp. 760–763, 1997. View at Google Scholar · View at Scopus
  81. I. M. Chapman, “The anorexia of aging,” Clinics in Geriatric Medicine, vol. 23, no. 4, pp. 735–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. V. Di Francesco, F. Fantin, F. Omizzolo et al., “The anorexia of aging,” Digestive Diseases, vol. 25, no. 2, pp. 129–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. N. P. Hays and S. B. Roberts, “The anorexia of aging in humans,” Physiology and Behavior, vol. 88, no. 3, pp. 257–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. E. Valassi, M. Scacchi, and F. Cavagnini, “Neuroendocrine control of food intake,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 18, no. 2, pp. 158–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. C. Kowalski, J. Micheau, R. Corder, R. Gaillard, and B. Conte-Devolx, “Age-related changes in cortico-releasing factor, somatostatin, neuropeptide Y, methionine enkephalin and β-endorphin in specific rat brain areas,” Brain Research, vol. 582, no. 1, pp. 38–46, 1992. View at Publisher · View at Google Scholar · View at Scopus
  86. D. A. Gruenewald, B. T. Marck, and A. M. Matsumoto, “Fasting-induced increases in food intake and neuropeptide Y gene expression are attenuated in aging male brown Norway rats,” Endocrinology, vol. 137, no. 10, pp. 4460–4467, 1996. View at Publisher · View at Google Scholar · View at Scopus
  87. T. M. McShane, M. E. Wilson, and P. M. Wise, “Effects of lifelong moderate caloric restriction on levels of neuropeptide Y, proopiomelanocortin, and Galanin mRNA,” Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 54, no. 1, pp. B14–B21, 1999. View at Publisher · View at Google Scholar · View at Scopus
  88. E. H. Sohn, T. Wolden-Hanson, and A. M. Matsumoto, “Testosterone (T)-induced changes in arcuate nucleus cocaine-amphetamine-regulated transcript and NPY mRNA are attenuated in old compared to young male brown Norway rats: contribution of T to age-related changes in cocaine-amphetamine- regulated transcript and NPY gene expression,” Endocrinology, vol. 143, no. 3, pp. 954–963, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. C. A. Blanton, B. A. Horwitz, J. E. Blevins, J. S. Hamilton, E. J. Hernandez, and R. B. McDonald, “Reduced feeding response to neuropeptide Y in senescent fischer 344 rats,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 280, no. 4, pp. R1052–R1060, 2001. View at Google Scholar · View at Scopus
  90. A. E. Rigamonti, A. I. Pincelli, B. Corrá et al., “Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients,” Journal of Endocrinology, vol. 175, no. 1, pp. R1–R5, 2002. View at Publisher · View at Google Scholar · View at Scopus
  91. A. E. Schutte, H. W. Huisman, R. Schutte, J. M. van Rooyen, L. Malan, and N. T. Malan, “Aging influences the level and functions of fasting plasma ghrelin levels: the POWIRS-Study,” Regulatory Peptides, vol. 139, no. 1–3, pp. 65–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. V. Di Francesco, M. Zamboni, E. Zoico et al., “Unbalanced serum leptin and ghrelin dynamics prolong postprandial satiety and inhibit hunger in healthy elderly: another reason for the ‘anorexia of aging’,” The American Journal of Clinical Nutrition, vol. 83, no. 5, pp. 1149–1152, 2006. View at Google Scholar · View at Scopus
  93. Y. Sun, J. M. Garcia, and R. G. Smith, “Ghrelin and growth hormone secretagogue receptor expression in mice during aging,” Endocrinology, vol. 148, no. 3, pp. 1323–1329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. H. Takeda, S. Muto, T. Hattori et al., “Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition,” Endocrinology, vol. 151, no. 1, pp. 244–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. J. M. Friedman and J. L. Halaas, “Leptin and the regulation of body weight in mammals,” Nature, vol. 395, no. 6704, pp. 763–770, 1998. View at Publisher · View at Google Scholar · View at Scopus
  96. C. F. Elias, C. Aschkenasi, C. Lee et al., “Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area,” Neuron, vol. 23, no. 4, pp. 775–786, 1999. View at Publisher · View at Google Scholar · View at Scopus
  97. J. K. Elmquist, “Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin,” Physiology and Behavior, vol. 74, no. 4-5, pp. 703–708, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. X.-M. Guan, H. Yu, O. C. Palyha et al., “Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues,” Molecular Brain Research, vol. 48, no. 1, pp. 23–29, 1997. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Traebert, T. Riediger, S. Whitebread, E. Scharrer, and H. A. Schmid, “Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus,” Journal of Neuroendocrinology, vol. 14, no. 7, pp. 580–586, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. R. Barazzoni, M. Zanetti, M. Stebel, G. Biolo, L. Cattin, and G. Guarnieri, “Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats,” Gastroenterology, vol. 124, no. 5, pp. 1188–1192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. D. Kohno, M. Nakata, F. Maekawa et al., “Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway,” Endocrinology, vol. 148, no. 5, pp. 2251–2263, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. J. Yao, J. P. Zhou, Q. N. Ping, Y. Lu, and L. Chen, “Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice,” International Journal of Pharmaceutics, vol. 352, no. 1-2, pp. 256–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. T. Matsumura, M. Arai, Y. Yonemitsu et al., “The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice,” Journal of Gastroenterology, vol. 45, no. 3, pp. 300–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Shiratori, T. Shoji, M. Kanazawa, M. Hongo, and S. Fukudo, “Effect of rikkunshito on gastric sensorimotor function under distention,” Neurogastroenterology & Motility, vol. 23, no. 4, pp. 323–e156, 2011. View at Google Scholar
  105. M. Arai, T. Matsumura, N. Tsuchiya et al., “Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin,” Hepato-Gastroenterology, vol. 59, no. 113, pp. 62–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Tominaga, M. Kato, H. Takeda et al., “A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study,” Journal of Gastroenterology, vol. 49, no. 10, pp. 1392–1405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. D. C. Currow and A. P. Abernethy, “Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome,” Future Oncology, vol. 10, no. 5, pp. 789–802, 2014. View at Publisher · View at Google Scholar · View at Scopus
  108. J. Seike, T. Sawada, N. Kawakita et al., “A new candidate supporting drug, rikkunshito, for the QOL in advanced esophageal cancer patients with chemotherapy using docetaxel/5-FU/CDDP,” International Journal of Surgical Oncology, vol. 2011, Article ID 715623, 7 pages, 2011. View at Publisher · View at Google Scholar
  109. T. Takahashi, S. Endo, K. Nakajima, Y. Souma, and T. Nishida, “Effect of rikkunshito, a Chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy,” World Journal of Surgery, vol. 33, no. 2, pp. 296–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Takiguchi, Y. Hiura, T. Takahashi et al., “Effect of rikkunshito, a Japanese herbal medicine, on gastrointestinal symptoms and ghrelin levels in gastric cancer patients after gastrectomy,” Gastric Cancer, vol. 16, no. 2, pp. 167–174, 2013. View at Publisher · View at Google Scholar · View at Scopus